Nandhu Mohan Sobhana

Company: Takeda Pharmaceutical

Job title: Head of Cell Therapy Innovation IND Engine

Seminars:

The Development of Vδ1 Gamma Delta T cell Platforms For Use In Next-Generation Allogeneic CAR Therapies 3:45 pm

Harnessing the potential of γδ T cells for immunotherapy in solid and hematological malignancies Investigating the advancements of allogeneic Vδ1 γδ T cell therapy platforms Preclinical update on the progress of cell therapy programs utilizing Vδ1 γδ T cellsRead more

day: Conference Day Two